Hypoxia-inducible adrenomedullin in colorectal cancer

Anticancer Research

Volumn 31, Issue 2, 2011, Pages 507-514

  Uemura, Mamoru ^a   Yamamoto, Hirofumi ^a   Takemasa, Ichiro ^a   Mimori, Koshi ^b   Mizushima, Tsunekazu ^a   Ikeda, Masataka ^a   Sekimoto, Mitsugu ^a   Doki, Yuichiro ^a   Mori, Masaki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

ADM; Colorectal cancer; Hypoxia; Prognostic factor

Indexed keywords

ADRENOMEDULLIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RELAPSE; COLORECTAL CANCER; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; HYPOXIA; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

ADRENOMEDULLIN; AGED; CELL HYPOXIA; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79953237875     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Semenza GL: Hypoxia and cancer. Cancer Metastasis Rev 26: 223-224, 2007.
2. Uemura M, Yamamoto H, Takemasa I, Mimori K, Hemmi H, Mizushima T, Ikeda M, Sekimoto M, Matsuura N, Doki Y and Mori M: Jumonji domain containing 1A is a novel prognostic marker for colorectal cancer: in vivo identification from hypoxic tumor cells. Clin Cancer Res 16: 4636-4646, 2010.
3. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H and Eto T: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192: 553-560, 1993. (Pubitemid 23227359)
4. Hinson JP, Kapas S and Smith DM: Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21: 138-167, 2000.
5. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
6. Ichiki Y, Kitamura K, Kangawa K, Kawamoto M, Matsuo H and Eto T: Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 338: 6-10, 1994.
7. Martinez A, Miller MJ, Unsworth EJ, Siegfried JM and Cuttitta F: Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology 136: 4099-4105, 1995.
8. Satoh F, Takahashi K, Murakami O, Totsune K, Sone M, Ohneda M, Abe K, Miura Y, Hayashi Y, Sasano H et al: Adrenomedullin in human brain, adrenal glands and tumor tissues of pheochromocytoma, ganglioneuroblastoma and neuroblastoma. J Clin Endocrinol Metab 80: 1750-1752, 1995.
9. Rocchi P, Boudouresque F, Zamora AJ, Muracciole X, Lechevallier E, Martin PM and Ouafik L: Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines. Cancer Res 61: 1196-1206, 2001. (Pubitemid 32174443)
10. Oehler MK, Fischer DC, Orlowska-Volk M, Herrle F, Kieback DG, Rees MC and Bicknell R: Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. Br J Cancer 89: 1927-1933, 2003.
11. Miller MJ, Martinez A, Unsworth EJ, Thiele CJ, Moody TW, Elsasser T and Cuttitta F: Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J Biol Chem 271: 23345-23351, 1996. (Pubitemid 26314779)
12. Ramachandran V, Arumugam T, Hwang RF, Greenson JK, Simeone DM and Logsdon CD: Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Cancer Res 67: 2666-2675, 2007. (Pubitemid 46548954)
13. Keleg S, Kayed H, Jiang X, Penzel R, Giese T, Buchler MW, Friess H and Kleeff J: Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion. Int J Cancer 121: 21-32, 2007. (Pubitemid 46759489)
14. Garayoa M, Martinez A, Lee S, Pio R, An WG, Neckers L, Trepel J, Montuenga LM, Ryan H, Johnson R, Gassmann M and Cuttitta F: Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol 14: 848-862, 2000. (Pubitemid 32260498)
15. Zhao Y, Hague S, Manek S, Zhang L, Bicknell R and Rees MC: PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene 16: 409-415, 1998. (Pubitemid 28052295)
16. Hague S, Zhang L, Oehler MK, Manek S, MacKenzie IZ, Bicknell R and Rees MC: Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density. Clin Cancer Res 6: 2808-2814, 2000. (Pubitemid 30482121)
17. Rees M, Hague S, Oehler MK and Bicknell R: Regulation of endometrial angiogenesis. Climacteric 2: 52-58, 1999.
18. Nikitenko LL, MacKenzie IZ, Rees MC and Bicknell R: Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium. Mol Hum Reprod 6: 811-819, 2000. (Pubitemid 30660613)
19. Oehler MK, Hague S, Rees MC and Bicknell R: Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis. Oncogene 21: 2815-2821, 2002. (Pubitemid 34499378)
20. Martinez A, Vos M, Guedez L, Kaur G, Chen Z, Garayoa M, Pio R, Moody T, Stetler-Stevenson WG, Kleinman HK and Cuttitta F: The effects of adrenomedullin overexpression in breast tumor cells. J Natl Cancer Inst 94: 1226-1237, 2002. (Pubitemid 34993873)
21. Fernandez-Sauze S, Delfino C, Mabrouk K, Dussert C, Chinot O, Martin PM, Grisoli F, Ouafik L and Boudouresque F: Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors. Int J Cancer 108: 797-804, 2004. (Pubitemid 38112605)
22. Zudaire E, Martinez A and Cuttitta F: Adrenomedullin and cancer. Regul Pept 112: 175-183, 2003.
23. Kato H, Shichiri M, Marumo F and Hirata Y: Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology 138: 2615-2620, 1997. (Pubitemid 27215270)
24. Shichiri M, Kato H, Doi M, Marumo F and Hirata Y: Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis. Mol Endocrinol 13: 1353-1363, 1999.
25. Sata M, Kakoki M, Nagata D, Nishimatsu H, Suzuki E, Aoyagi T, Sugiura S, Kojima H, Nagano T, Kangawa K, Matsuo H, Omata M, Nagai R and Hirata Y: Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism. Hypertension 36: 83-88, 2000. (Pubitemid 30602157)
26. Rebuffat P, Forneris ML, Aragona F, Ziolkowska A, Malendowicz LK and Nussdorfer GG: Adrenomedullin and its receptors are expressed in the zona glomerulosa of human adrenal gland: evidence that ADM enhances proliferation and decreases apoptosis in cultured ZG cells. Int J Mol Med 9: 119-124, 2002.
27. Kamoi H, Kanazawa H, Hirata K, Kurihara N, Yano Y and Otani S: Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of the interleukin-8 family, from rat alveolar macrophages. Biochem Biophys Res Commun 211: 1031-1035, 1995.
28. Pio R, Martinez A, Unsworth EJ, Kowalak JA, Bengoechea JA, Zipfel PF, Elsasser TH and Cuttitta F: Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J Biol Chem 276: 12292-12300, 2001.
29. Hsieh FC, Cheng G and Lin J: Evaluation of potential STAT3-regulated genes in human breast cancer. Biochem Biophys Res Commun 335: 292-299, 2005. (Pubitemid 41140220)
30. Chapuis PH, Dent OF, Fisher R, Newland RC, Pheils MT, Smyth E and Colquhoun K: A multivariate analysis of clinical and pathological variables in prognosis after resection of large bowel cancer. Br J Surg 72: 698-702, 1985. (Pubitemid 16215165)
31. Koyama Y and Kotake K: Overview of colorectal cancer in Japan: report from the Registry of the Japanese Society for Cancer of the Colon and Rectum. Dis Colon Rectum 40: S2-9, 1997.
32. Ratto C, Sofo L, Ippoliti M, Merico M, Doglietto GB and Crucitti F: Prognostic factors in colorectal cancer. Literature review for clinical application. Dis Colon Rectum 41: 1033-1049, 1998.
33. Gennari L, Doci R and Rossetti C: Prognostic factors in colorectal cancer. Hepatogastroenterology 47: 310-314, 2000.
34. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, Miedema B, Ota D and Sargent D: Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93: 583-596, 2001.
35. Nagaya N, Mori H, Murakami S, Kangawa K and Kitamura S: Adrenomedullin: angiogenesis and gene therapy. Am J Physiol Regul Integr Comp Physiol 288: R1432-1437, 2005.